Construction and in vivo/in vitro evaluation of a nanoporous ion-responsive targeted drug delivery system for recombinant human interferon α-2b delivery
Hongfei Liu,1 Jie Zhu,1 Pengyue Bao,2 Yueping Ding,3 Yan Shen,4 Thomas J Webster,5 Ying Xu11College of Pharmacy, Jiangsu University, Zhenjiang 212013, People’s Republic of China; 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing 210023, People’s Republic of China; 3Jiangs...
Guardado en:
Autores principales: | Liu H, Zhu J, Bao P, Ding Y, Shen Y, Webster TJ, Xu Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fa1b39c66114f4fbf19bcc90d3b4a36 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LOCAL APPLICATION OF RECOMBINANT INTERFERON-ALFA2 FOR TREATMENT OF RECURRENT RESPIRATORY PAPILLOMATOSIS
por: M. Plouzhnikov, et al.
Publicado: (2014) -
The effect of recombinant human interferon α1b treatment of infants hospitalized with lower respiratory tract infection on subsequent wheezing
por: Lihua Yang, et al.
Publicado: (2021) -
Hormone therapy affecting interferon defense in children with infectious mononucleosis
por: I. M. Fedorova, et al.
Publicado: (2021) -
Is Interferon α-2b 1 MillionIU/mL Truly Better Than Tacrolimus 0.03% for Steroid-Resistant VKC ?: Our 2-Year Experience at a Tertiary Health-Care Centre
por: Gupta S, et al.
Publicado: (2021) -
Interferons in Pain and Infections: Emerging Roles in Neuro-Immune and Neuro-Glial Interactions
por: Ping-Heng Tan, et al.
Publicado: (2021)